Immunization against Lyme Disease — An Important First Step
- 23 July 1998
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (4) , 263-264
- https://doi.org/10.1056/nejm199807233390409
Abstract
Lyme disease is an inflammatory disorder that can involve the skin and the musculoskeletal, neurologic, and cardiovascular systems.1 The etiologic agent, Borrelia burgdorferi, was isolated from tick vectors in 19822 and subsequently from patients in 1983.3,4 Lyme disease is the most common vector-borne disease in the United States, with 16,461 cases reported to the Centers for Disease Control and Prevention in 1996.5 Although cases have been reported in 45 states, they are clustered in the mid-Atlantic, Northeast, and North Central regions. The prevalence of Lyme disease is affected by the proportions of infected small-mammal reservoirs, tick vectors, and their . . .Keywords
This publication has 9 references indexed in Scilit:
- A Vaccine Consisting of RecombinantBorrelia burgdorferiOuter-Surface Protein A to Prevent Lyme DiseaseNew England Journal of Medicine, 1998
- Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with AdjuvantNew England Journal of Medicine, 1998
- The Consequences of Overdiagnosis and Overtreatment of Lyme Disease: An Observational StudyAnnals of Internal Medicine, 1998
- Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferiNature, 1997
- IMMUNIZATIONInfectious Disease Clinics of North America, 1995
- The Biological and Social Phenomenon of Lyme DiseaseScience, 1993
- Spirochetes Isolated from the Blood of Two Patients with Lyme DiseaseNew England Journal of Medicine, 1983
- The Spirochetal Etiology of Lyme DiseaseNew England Journal of Medicine, 1983
- Lyme Disease—a Tick-Borne Spirochetosis?Science, 1982